These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Comparison of five methods, including the PDM Epsilometer test (E test), for antimicrobial susceptibility testing of Pseudomonas aeruginosa. Joyce LF; Downes J; Stockman K; Andrew JH J Clin Microbiol; 1992 Oct; 30(10):2709-13. PubMed ID: 1400972 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of the VITEK 2 system for the identification and susceptibility testing of three species of nonfermenting gram-negative rods frequently isolated from clinical samples. Joyanes P; del Carmen Conejo M; Martínez-Martínez L; Perea EJ J Clin Microbiol; 2001 Sep; 39(9):3247-53. PubMed ID: 11526158 [TBL] [Abstract][Full Text] [Related]
6. [Performance evaluation of VITEK 2 system in meropenem susceptibility testing of clinical Pseudomonas aeruginosa isolates]. Acuner IC; Bayramoğlu G; Birinci A; Cekiç Cihan C; Bek Y; Durupınar B Mikrobiyol Bul; 2011 Jul; 45(3):411-21. PubMed ID: 21935774 [TBL] [Abstract][Full Text] [Related]
7. Ceftolozane/tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing urinary tract and intraabdominal infections in Europe: report from an antimicrobial surveillance programme (2012-15). Pfaller MA; Bassetti M; Duncan LR; Castanheira M J Antimicrob Chemother; 2017 May; 72(5):1386-1395. PubMed ID: 28165526 [TBL] [Abstract][Full Text] [Related]
8. Performance of VITEK-2 Compact and overnight MicroScan panels for direct identification and susceptibility testing of Gram-negative bacilli from positive FAN BacT/ALERT blood culture bottles. Quesada MD; Giménez M; Molinos S; Fernández G; Sánchez MD; Rivelo R; Ramírez A; Banqué G; Ausina V Clin Microbiol Infect; 2010 Feb; 16(2):137-40. PubMed ID: 19778301 [TBL] [Abstract][Full Text] [Related]
9. Accuracy of three automated systems (MicroScan WalkAway, VITEK, and VITEK 2) for susceptibility testing of Pseudomonas aeruginosa against five broad-spectrum beta-lactam agents. Sader HS; Fritsche TR; Jones RN J Clin Microbiol; 2006 Mar; 44(3):1101-4. PubMed ID: 16517904 [TBL] [Abstract][Full Text] [Related]
10. Susceptibility of current clinical isolates of Pseudomonas aeruginosa and enteric gram-negative bacilli to amikacin and other aminoglycoside antibiotics. Dámaso D; Moreno-López M; Martínez-Beltrán J; García-Iglesias MC J Infect Dis; 1976 Nov; 134 SUPPL():S394-90. PubMed ID: 825591 [TBL] [Abstract][Full Text] [Related]
11. In vitro activity of ceftolozane/tazobactam against clinical isolates of Pseudomonas aeruginosa and Enterobacteriaceae recovered in Spanish medical centres: Results of the CENIT study. Tato M; García-Castillo M; Bofarull AM; Cantón R; Int J Antimicrob Agents; 2015 Nov; 46(5):502-10. PubMed ID: 26315199 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of the AutoMicrobic system for susceptibility testing of aminoglycosides and gram-negative bacilli. Hindler JA; Bruckner DA J Clin Microbiol; 1987 Mar; 25(3):546-50. PubMed ID: 3571458 [TBL] [Abstract][Full Text] [Related]
13. Antimicrobial activity of ceftolozane/tazobactam tested against Pseudomonas aeruginosa and Enterobacteriaceae with various resistance patterns isolated in European hospitals (2011-12). Sader HS; Farrell DJ; Castanheira M; Flamm RK; Jones RN J Antimicrob Chemother; 2014 Oct; 69(10):2713-22. PubMed ID: 24917579 [TBL] [Abstract][Full Text] [Related]
14. Multicenter laboratory evaluation of the bioMérieux Vitek antimicrobial susceptibility testing system with 11 antimicrobial agents versus members of the family Enterobacteriaceae and Pseudomonas aeruginosa. Doern GV; Brueggemann AB; Perla R; Daly J; Halkias D; Jones RN; Saubolle MA J Clin Microbiol; 1997 Aug; 35(8):2115-9. PubMed ID: 9230393 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of the automicrobic system for susceptibility testing of Pseudomonas aeruginosa to gentamicin, tobramycin, and amikacin. Woolfrey BF; Lally RT; Ederer MN; Quall CO J Clin Microbiol; 1984 Apr; 19(4):502-5. PubMed ID: 6425360 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of the AutoMicrobic system for identification and susceptibility testing of gram-negative bacilli. Woolfrey BF; Lally RT; Ederer MN; Quall CO J Clin Microbiol; 1984 Dec; 20(6):1053-9. PubMed ID: 6520216 [TBL] [Abstract][Full Text] [Related]
17. Clinical evaluation of new AMS GSC plus card. Dudley M; Nauschuetz WF; Juchau SV Diagn Microbiol Infect Dis; 1983 Jun; 1(2):139-43. PubMed ID: 6425001 [TBL] [Abstract][Full Text] [Related]
19. Comparison of workflow and accuracy of identification and antimicrobial susceptibility testing of clinical isolates of Enterobacteriaceae, Pseudomonas aeruginosa and enterococci by Vitek 2 and routine methods. Rantakokko-Jalava K; Elo-Lehtonen E; Meurman O APMIS; 2006 Jan; 114(1):43-9. PubMed ID: 16499660 [TBL] [Abstract][Full Text] [Related]
20. Accuracy and reproducibility of the AutoMicrobic System Gram-Negative General Susceptibility-Plus Card for testing selected challenge organisms. Nadler HL; Dolan C; Mele L; Kurtz SR J Clin Microbiol; 1985 Sep; 22(3):355-60. PubMed ID: 3930559 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]